Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 20UNKNOWN 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 1Brain Neoplasms 1

Interventions

Capecitabine 15Paclitaxel 13S 1 (combination) 9apatinib 8Oxaliplatin 8Carboplatin 8Cisplatin 7pyrotinib 6Epirubicin 6Docetaxel 6sintilimab 5camrelizumab 5anlotinib 5Radiotherapy 5Drug Therapy 5130-nm albumin-bound paclitaxel 5nimotuzumab 4nedaplatin 4Vinorelbine 4Temozolomide 4Irinotecan 4Fulvestrant 4Etoposide 4Bevacizumab 4toripalimab 3titanium silicide 3exemestane 3Trastuzumab 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Radiation Dose Hypofractionation × Clear all
NCT05045287 2021-09-16

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

ChineseAMS

Phase NA Unknown
57 enrolled
Breast

Breast Neoplasms

NCT03778541 2019-07-23

HFSRT With Concurrent TMZ for Large BMs

ChineseAMS

Phase 3 Unknown
224 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡